What are the ACR/Arthritis Foundation recommendations for pharmacologic treatment of osteoarthritis (OA) of the hip?

Updated: Oct 12, 2020
  • Author: Carlos J Lozada, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print

For pharmacologic treatment of hip osteoarthritis, the ACR/Arthritis Foundation guidelines strongly recommend the following [154]

  • Oral nonsteroidal anti-inflammatory drugs (NSAIDs); however, doses should be as low as possible and treatment should be as short as possible
  • Intra-articular glucocorticoid injections
  • Ultrasound guidance for glucocorticoid injections into hip joints

Conditionally recommended agents include the following [154] :

  • Topical capsaicin
  • Acetaminophen
  • Duloxetine
  • Tramadol

The ACR/Arthritis Foundation guidelines conditionally recommend against use of the following for hip osteoarthritis:

  • Non‐tramadol opioids (with the recognition that they may be used under certain circumstances, particularly when alternatives have been exhausted)
  • Intra-articular botulinum toxin injections
  • Colchicine
  • Fish oil
  • Vitamin D
  • Prolotherapy

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!